Trial Profile
Randomised, Evaluator-Blinded, Multicentre, International, Parallel-Group, Active-Controlled Clinical Trial of Gusperimus Versus Conventional Therapy in Relapse of Granulomatosis With Polyangiitis (Wegener's Granulomatosis) SPARROW Study - SPAnidin in Relapsing GRanulomatosis With POlyangiitis Wegener's Granulomatosis)
Status:
Discontinued
Phase of Trial:
Phase III
Latest Information Update: 01 Jul 2019
Price :
$35
*
At a glance
- Drugs Gusperimus (Primary) ; Azathioprine; Cyclophosphamide; Glucocorticoids; Methotrexate; Methotrexate
- Indications Granulomatosis with polyangiitis
- Focus Registrational; Therapeutic Use
- Acronyms SPARROW
- Sponsors Nordic Drugs
- 21 Jan 2015 Status changed from suspended to discontinued as reported by ClinicalTrials.gov record.
- 30 Mar 2014 New trial record